Status: Approved
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Brain Diseases; Hemorrhage; Hepatic Encephalopathy Phase 4 ClinicalTrials
Hepatic Insufficiency; Liver Failure; Liver Failure, Acute Phase 2 ClinicalTrials
Ascites; Fibrosis; Hypertension, Portal Phase 2/Phase 3 ClinicalTrials
Brain Diseases; Hepatic Encephalopathy Phase 3 ClinicalTrials
Brain Diseases; Hepatic Encephalopathy Phase 4 ClinicalTrials
Brain Diseases; Hepatic Encephalopathy Phase 4 ClinicalTrials
Brain Diseases; Fibrosis; Hepatic Encephalopathy; Liver Cirrhosis Phase 4 ClinicalTrials
CONTENTS